trending Market Intelligence /marketintelligence/en/news-insights/trending/o9keoxk79nabukgylcdn0a2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Oncobiologics CEO steps down; interim replacement named

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Oncobiologics CEO steps down; interim replacement named

Oncobiologics Inc. said its founder Pankaj Mohan stepped down from the positions of chairman and CEO, effective June 18.

The Cranbury, N.J.-based biopharmaceutical company said Mohan will remain a board member and will enter into a consulting agreement to provide advisory services in connection with the development of its product candidate ONS-5010.

Oncobiologics said board member Randy Thurman will assume the role of executive chairman and CFO Lawrence Kenyon will serve as interim CEO.

Thurman joined Oncobiologics' board in April, while Kenyon joined the company as CFO and corporate secretary in September 2015.

Oncobiologics' board has formed a search committee to find a permanent CEO.